Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
$0.00
$0.00
▼
$0.00
N/A0.33N/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$4.82
+0.7%
$4.77
$4.45
▼
$11.67
$234.38M0.91572,158 shs134,058 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
0.00%0.00%0.00%0.00%-50.00%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
+2.91%+1.92%+3.69%-9.99%-55.54%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
$0.00
$0.00
▼
$0.00
N/A0.33N/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$4.82
+0.7%
$4.77
$4.45
▼
$11.67
$234.38M0.91572,158 shs134,058 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
0.00%0.00%0.00%0.00%-50.00%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
+2.91%+1.92%+3.69%-9.99%-55.54%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
0.00
N/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
1.50
ReduceN/AN/A

Current Analyst Ratings Breakdown

Latest BIOAF and NUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/12/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
UpgradeStrong Sell ➝ Hold
8/14/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
DowngradeHold ➝ Strong Sell
8/11/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
DowngradeSell (D+) ➝ Sell (D)
(Data available from 11/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
N/AN/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$1.38B0.17$2.44 per share1.97$16.71 per share0.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$160.20M-$4.47N/A4.15N/A-15.73%6.58%3.63%11/5/2026 (Estimated)

Latest BIOAF and NUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.21N/AN/AN/A$328.70 millionN/A
8/10/2026Q2 2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.20$0.20N/A-$5.14$345.20 million$320.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
N/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.244.98%-30.69%N/A N/A

Latest BIOAF and NUS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/10/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
quarterly$0.064.92%8/28/20268/28/20269/9/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
N/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.36
1.98
1.24

Institutional Ownership

CompanyInstitutional Ownership
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
N/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
82.84%

Insider Ownership

CompanyInsider Ownership
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
N/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioasis Technologies Inc. stock logo
BIOAF
Bioasis Technologies
4N/AN/ANot Optionable
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2,80048.68 million47.31 millionOptionable

Recent News About These Companies

NUS - Nu Skin Enterprises, Inc.
Nu Skin Enterprises stock holds as revenue rebuilds
Why Nu Skin (NYSE:NUS) Retail Stock Draws Attention?
Nu Skin Enterprises Reports Second Quarter Results
Nu Skin Enterprises Announces Quarterly Dividend

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bioasis Technologies stock logo

Bioasis Technologies OTCMKTS:BIOAF

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane's OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis' xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Nu Skin Enterprises stock logo

Nu Skin Enterprises NYSE:NUS

$4.82 +0.04 (+0.73%)
As of 01:02 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.